Opioids and Kidney Stones

Christina Kottooran; Kevan Sternberg; Karen L Stern; Vernon M Pais Jr; Brian H Eisner

doi:10.1016/j.semnephrol.2021.03.002

Opioids and Kidney Stones

Semin Nephrol. 2021 Jan;41(1):19-23. doi: 10.1016/j.semnephrol.2021.03.002.

Authors

Christina Kottooran¹, Kevan Sternberg², Karen L Stern³, Vernon M Pais Jr⁴, Brian H Eisner⁵

Affiliations

¹ Massachusetts General Hospital, Harvard Medical School, Boston, MA.
² University of Vermont Medical Center, Burlington, VT.
³ Mayo Clinic, Phoenix, AZ.
⁴ Dartmouth-Hitchcock Medical Center, Lebanon, NH.
⁵ Massachusetts General Hospital, Harvard Medical School, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: beisner@mgh.harvard.edu.

PMID: 33896469
DOI: 10.1016/j.semnephrol.2021.03.002

Abstract

In recent years, the use of opioids in medical practice has come under significant scrutiny. This, in part, is owing to evidence of overprescription and overuse of opioid medications, as well as the unintended consequences and side effects for patients who take these medications. Here, we review the role of opioids and the responsible use of these medications with respect to kidney stone disease and surgical interventions for kidney stones.

Keywords: Kidney stone; opioids; pain; ureteroscopy.

Publication types

Review

MeSH terms

Analgesics, Opioid* / adverse effects
Humans
Kidney Calculi* / chemically induced
Treatment Outcome
Ureteroscopy

Substances

Analgesics, Opioid